The University of Minnesota has filed a lawsuit against Gilead Sciences claiming that the drugmaker’s hepatitis C drugs violate its intellectual property.
AbbVie has filed a lawsuit in the US seeking to block Amgen from selling a biosimilar of its arthritis blockbuster Humira, the world’s second-biggest selling drug.